These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 37838102)
1. GW9662 ameliorates nonalcoholic steatohepatitis by inhibiting the PPARγ/CD36 pathway and altering the gut microbiota. Xiao J; Xiang H; Xiang H; Sun Z; Xu J; Ren H; Hu P; Peng M Eur J Pharmacol; 2023 Dec; 960():176113. PubMed ID: 37838102 [TBL] [Abstract][Full Text] [Related]
2. Folic acid attenuates high-fat diet-induced steatohepatitis Xin FZ; Zhao ZH; Zhang RN; Pan Q; Gong ZZ; Sun C; Fan JG World J Gastroenterol; 2020 May; 26(18):2203-2220. PubMed ID: 32476787 [TBL] [Abstract][Full Text] [Related]
3. Qingrequzhuo capsule alleviated methionine and choline deficient diet-induced nonalcoholic steatohepatitis in mice through regulating gut microbiota, enhancing gut tight junction and inhibiting the activation of TLR4/NF-κB signaling pathway. Lv S; Zhang Z; Su X; Li W; Wang X; Pan B; Li H; Zhang H; Wang Y Front Endocrinol (Lausanne); 2022; 13():1106875. PubMed ID: 36743916 [TBL] [Abstract][Full Text] [Related]
4. Rifaximin alleviates MCD diet-induced NASH in mice by restoring the gut microbiota and intestinal barrier. Shu YY; Hu LL; Ye J; Yang L; Jin Y Life Sci; 2024 Nov; 357():123095. PubMed ID: 39368771 [TBL] [Abstract][Full Text] [Related]
5. Aqueous extract of Polygala japonica Houtt. ameliorated nonalcoholic steatohepatitis in mice through restoring the gut microbiota disorders and affecting the metabolites in feces and liver. Liao J; Cao Y; Zhao J; Yu B; Wang Y; Li W; Li H; Lv S; Wen W; Cui H; Chen Y Phytomedicine; 2023 Sep; 118():154937. PubMed ID: 37393831 [TBL] [Abstract][Full Text] [Related]
6. Nonalcoholic Fatty Liver Disease Is Exacerbated in High-Fat Diet-Fed Gnotobiotic Mice by Colonization with the Gut Microbiota from Patients with Nonalcoholic Steatohepatitis. Chiu CC; Ching YH; Li YP; Liu JY; Huang YT; Huang YW; Yang SS; Huang WC; Chuang HL Nutrients; 2017 Nov; 9(11):. PubMed ID: 29113135 [TBL] [Abstract][Full Text] [Related]
7. Ileal Bile Acid Transporter Inhibitor Improves Hepatic Steatosis by Ameliorating Gut Microbiota Dysbiosis in NAFLD Model Mice. Matsui M; Fukunishi S; Nakano T; Ueno T; Higuchi K; Asai A mBio; 2021 Aug; 12(4):e0115521. PubMed ID: 34225483 [TBL] [Abstract][Full Text] [Related]
8. Smilax China L. polysaccharide prevents HFD induced-NAFLD by regulating hepatic fat metabolism and gut microbiota. Zhang W; Yu L; Yang Q; Zhang J; Wang W; Hu X; Li J; Zheng G Phytomedicine; 2024 May; 127():155478. PubMed ID: 38452696 [TBL] [Abstract][Full Text] [Related]
9. Alisol B Alleviates Hepatocyte Lipid Accumulation and Lipotoxicity via Regulating RARα-PPARγ-CD36 Cascade and Attenuates Non-Alcoholic Steatohepatitis in Mice. Zhao Z; Deng ZT; Huang S; Ning M; Feng Y; Shen Y; Zhao QS; Leng Y Nutrients; 2022 Jun; 14(12):. PubMed ID: 35745142 [TBL] [Abstract][Full Text] [Related]
10. Chaihu Guizhi Ganjiang Decoction attenuates nonalcoholic steatohepatitis by enhancing intestinal barrier integrity and ameliorating PPARα mediated lipotoxicity. Wu H; Lou T; Pan M; Wei Z; Yang X; Liu L; Feng M; Shi L; Qu B; Cong S; Chen K; Yang H; Liu J; Li Y; Jia Z; Xiao H J Ethnopharmacol; 2024 May; 326():117841. PubMed ID: 38310988 [TBL] [Abstract][Full Text] [Related]
11. Effects of Tylophora yunnanensis Schltr on regulating the gut microbiota and its metabolites in non-alcoholic steatohepatitis rats by inhibiting the activation of NOD-like receptor protein 3. Lin YP; Fang QL; Xue YM; Fu SN; Hu CY; Huang F; Wang MM; Qiao X; Yin XQ; Zeng YC; Du CH; Zhao XJ; Li XP; Hua Y J Ethnopharmacol; 2023 Apr; 305():116145. PubMed ID: 36623753 [TBL] [Abstract][Full Text] [Related]
12. Artemisia argyi ethanol extract ameliorates nonalcoholic steatohepatitis-induced liver fibrosis by modulating gut microbiota and hepatic signaling. Erdenebileg S; Kim M; Nam Y; Cha KH; Le TT; Jung SH; Nho CW J Ethnopharmacol; 2024 Oct; 333():118415. PubMed ID: 38848971 [TBL] [Abstract][Full Text] [Related]
13. Honokiol attenuates diet-induced non-alcoholic steatohepatitis by regulating macrophage polarization through activating peroxisome proliferator-activated receptor γ. Zhong X; Liu H J Gastroenterol Hepatol; 2018 Feb; 33(2):524-532. PubMed ID: 28670854 [TBL] [Abstract][Full Text] [Related]
14. Fructooligosaccharides attenuate non-alcoholic fatty liver disease by remodeling gut microbiota and association with lipid metabolism. Huang X; Chen Q; Fan Y; Yang R; Gong G; Yan C; Song Y; Zhang B; Xi S; Huang Y; Xu H Biomed Pharmacother; 2023 Mar; 159():114300. PubMed ID: 36696803 [TBL] [Abstract][Full Text] [Related]
15. Tangshen formula targets the gut microbiota to treat non-alcoholic fatty liver disease in HFD mice: A 16S rRNA and non-targeted metabolomics analyses. Wang S; Li X; Zhang B; Li Y; Chen K; Qi H; Gao M; Rong J; Liu L; Wan Y; Dong X; Yan M; Ma L; Li P; Zhao T Biomed Pharmacother; 2024 Apr; 173():116405. PubMed ID: 38484559 [TBL] [Abstract][Full Text] [Related]
16. Ginsenoside Rg Shi Y; Chen J; Qu D; Sun Q; Yu Y; Zhang H; Liu Z; Sha J; Sun Y Nutrients; 2024 Mar; 16(6):. PubMed ID: 38542753 [TBL] [Abstract][Full Text] [Related]
17. Tian G; Wang W; Xia E; Chen W; Zhang S Front Cell Infect Microbiol; 2023; 13():1078447. PubMed ID: 36860985 [TBL] [Abstract][Full Text] [Related]
19. Lingguizhugan decoction improves non-alcoholic steatohepatitis partially by modulating gut microbiota and correlated metabolites. Zhu M; Wang X; Wang K; Zhao Z; Dang Y; Ji G; Li F; Zhou W Front Cell Infect Microbiol; 2023; 13():1066053. PubMed ID: 36779187 [TBL] [Abstract][Full Text] [Related]
20. Fufang Zhenzhu Tiaozhi Capsule Prevents Intestinal Inflammation and Barrier Disruption in Mice With Non-Alcoholic Steatohepatitis. Lan T; Xu T; Fu Y; Jiang S; Liang X; Yu Z; Pan L; Rong X; Guo J Front Endocrinol (Lausanne); 2022; 13():864703. PubMed ID: 35784533 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]